Literature DB >> 20473151

Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation.

Herbert Tilg1, Alexander Moschen.   

Abstract

PURPOSE OF REVIEW: Nonalcoholic fatty liver disease (NAFLD) is one of the most prevalent liver diseases worldwide. Advanced age, extensive overweight and a number of features of the metabolic syndrome are associated with NAFLD severity. The cause of NAFLD is considered multifactorial with a substantial genetic component. RECENT
FINDINGS: Family members of children with NAFLD demonstrate a higher risk for NAFLD. Whereas such an association only suggests that familial factors are major determinants of whether or not an individual will develop NAFLD, recent genome-wide association studies were able to identify first candidate genes. An allele in patatin-like phospholipase 3, encoding a protein of unknown function with homology to lipid acyl hydrolases, is strongly associated with increased hepatic fat and inflammation. Apolipoprotein C3 gene variants are also associated with NAFLD and insulin resistance. Several other genetic variants have been identified, although with less convincing evidence. These genetic variants involve molecules regulating insulin signaling, lipid metabolism, oxidative stress or fibrogenesis. Furthermore, genetic variants of several cytokines and adipocytokines have been associated with NAFLD.
SUMMARY: Several genetic factors such as patatin-like phospholipase 3 or apolipoprotein C3 have been recently characterized in NAFLD. Further studies to identify their interaction with environmental factors are eagerly warranted.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20473151     DOI: 10.1097/MCO.0b013e32833a87cc

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  10 in total

1.  "The metabolic syndrome... is dead": these reports are an exaggeration.

Authors:  Alexander Tenenbaum; Enrique Z Fisman
Journal:  Cardiovasc Diabetol       Date:  2011-01-27       Impact factor: 9.951

2.  Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes.

Authors:  Albrecht Ingo Schmid; Julia Szendroedi; Marek Chmelik; Martin Krssák; Ewald Moser; Michael Roden
Journal:  Diabetes Care       Date:  2011-01-07       Impact factor: 19.112

Review 3.  Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases.

Authors:  Sha Li; Ming Hong; Hor-Yue Tan; Ning Wang; Yibin Feng
Journal:  Oxid Med Cell Longev       Date:  2016-12-14       Impact factor: 6.543

4.  Association of patatin-like phospholipase domain-containing protein 3 gene polymorphisms with susceptibility of nonalcoholic fatty liver disease in a Han Chinese population.

Authors:  Guohe Song; Chao Xiao; Kai Wang; Yupeng Wang; Jian Chen; Yang Yu; Zhaowen Wang; Guilong Deng; Xing Sun; Lin Zhong; Chongzhi Zhou; Xiaosheng Qi; Shuyun Wang; Zhihai Peng; Xiaoliang Wang
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

Review 5.  Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease.

Authors:  Adriana Fontes; Mireia Alemany-Pagès; Paulo J Oliveira; João Ramalho-Santos; Hans Zischka; Anabela Marisa Azul
Journal:  Int J Mol Sci       Date:  2019-08-16       Impact factor: 5.923

6.  Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease.

Authors:  Salvatore Petta; Luca Miele; Elisabetta Bugianesi; Calogero Cammà; Chiara Rosso; Stefania Boccia; Daniela Cabibi; Vito Di Marco; Stefania Grimaudo; Antonio Grieco; Rosaria Maria Pipitone; Giulio Marchesini; Antonio Craxì
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

7.  Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease.

Authors:  Yusuf Yilmaz; Talat Ayyildiz; Hakan Akin; Yasar Colak; Oguzhan Ozturk; Ebubekir Senates; Ilyas Tuncer; Enver Dolar
Journal:  Gut Liver       Date:  2014-05       Impact factor: 4.519

Review 8.  A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence.

Authors:  Jonathan L Temple; Paul Cordero; Jiawei Li; Vi Nguyen; Jude A Oben
Journal:  Int J Mol Sci       Date:  2016-06-15       Impact factor: 5.923

9.  Assessment of mitochondrial function in metabolic dysfunction-associated fatty liver disease using obese mouse models.

Authors:  Qiong-Ya Zhao; Ling-Hong Ge; Kun Zhang; Hai-Feng Chen; Xin-Xin Zhan; Yue Yang; Qing-Lin Dang; Yi Zheng; Huai-Bin Zhou; Jian-Xin Lyu; He-Zhi Fang
Journal:  Zool Res       Date:  2020-09-18

10.  Aberrant FGFR4 signaling worsens nonalcoholic steatohepatitis in FGF21KO mice.

Authors:  Youxi Yu; Xiaoju Shi; Qianqian Zheng; Xingtong Wang; Xingkai Liu; Min Tan; Guoyue Lv; Ping Zhang; Robert C Martin; Yan Li
Journal:  Int J Biol Sci       Date:  2021-06-22       Impact factor: 6.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.